drugset / Trial / NCT06086912

A Clinical Study to Compare the Bioavailability of HR17031 in Healthy Subjects at Different Sites

NCT06086912

Phase 1 Completed 24 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the bioavailability and safety of HR17031 injection in healthy subjects at different sites.

Timeline

Start
2023-11-07
Primary completion
2023-12-12
Completion
2023-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject HR17031 Unknown